Back

This is mind blowing 🤯. The farmaceutical business is really the whale 🐋. ➡️ This Bangalore based Pharmacy-focused supply chain and marketplace platform Saveo has achieved remarkable growth, scaling 103X 🔥since its inception. ➡️In 2020 their reve

Do you agree **Two types of startups dominate India today:** 1. **Profit-focused startups** – They grow steadily, solve real problems, and build sustainable models. 2. **Valuation-focused startups** – They chase funding, burn cash on discounts, an

Our Latest Mandate As part of growth strategy of one of our clients they are actively exploring acquisition opportunities across the following areas: • Specialty Chemicals (EBITDA ≥ ₹25 Cr, export-ready, asset-backed) • Food Processing (EBITDA ≥ ₹10

Unique Startup Stories (12/20) Meet DeHaat, a $600 Million Agritech startup from Patna. About It • It was Founded by Amrendra Singh and Shashank Kumar in Patna, Bihar in 2012. • It provides quality agricultural resources, financial support, and a m

Top News of the Week: 1. Funding: - 25 Indian startups raised around $432 million in funding. These deals count 6 growth-stage deals and 16 early-stage deals while 3 early-stage startups kept their transaction details undisclosed. - On a weekly b

Growth hides flaws. Crisis shows if you really have a business. That’s exactly what happened with Fittr. During COVID, Fittr became the poster child of India’s online fitness boom. Revenue soared from ₹58 Cr to ₹90 Cr. Investors rushed in. But beh

Failed in his first startup, built a 16,100 CR company after, IPO oversubscribed by 109 times. 1. After completing his electrical engineering at IIT Kanpur and an MBA from IIM Ahmedabad, Abhiraj Singh Bahl began his career as a strategic consultant

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

Antfin, an affiliate of Alibaba Group, is reportedly set to sell 18.8 Cr shares of foodtech major Eternal in a block deal worth around INR 5,375 Cr (about $613 Mn). This comes a day after the investor exited fintech major Paytm. Citing sources, CNBC

Our Latest Mandate As part of growth strategy of one of our clients they are actively exploring acquisition opportunities across the following areas: • Specialty Chemicals (EBITDA ≥ ₹25 Cr, export-ready, asset-backed) • Food Processing (EBITDA ≥ ₹10